Over 50 million people globally are impacted by dementia. 25% of those over age 55 have a family history of dementia.*

Tesis Labs Parkinson-Alzheimer-Dementia Panel examines 35 genes associated with an increased risk of developing neurodegenerative conditions: • Parkinson’s disease • Alzheimer’s disease • Genetic disorders that cause dementia.

What are the benefits of testing?

Patients identified with a positive test result have an increased risk of developing the associated neurodegenerative disease. Genetic testing may be beneficial in the planning and decision-making process for treatment, psychosocial counseling, research study enrollment, and support programs for caregivers and patients.

The patient’s family members can also be tested to help define their risk. A positive test result for the patient increases the risk for their relatives up to 50%.